News 
Nimbus Synergies Leads $20 Million Strategic Investment in Clarius Mobile Health to Accelerate Growth
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce the completion of a $20 million strategic investment in Clarius Mobile Health. This new investment was led by Nimbus Synergies and Export Development Canada to enable Clarius to expand its commercial scale and capitalize on the momentum created by the introduction of the company’s third-generation product line earlier this year.
Nimbus Synergies Portfolio Company ALAViDA Acquired by LifeSpeak to Deliver Substance Use Support to Millions of People Globally
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce that ALAViDA Health Ltd. (“ALAViDA”), one of its earliest portfolio companies, was acquired by LifeSpeak Inc. (TSX: LSPK) in October 2021.
Nimbus Synergies Portfolio Company Blue Mesa Health Acquired by Virgin Pulse
Vancouver, British Columbia, January 15, 2020 – Nimbus Synergies, investor, partner, and mentor to British Columbia’s leading health technology companies, is pleased to announce that Blue Mesa Health, one of its portfolio companies, has been acquired by Virgin Pulse, the leading global provider of enterprise SaaS solutions that simplify health and wellbeing.
Nimbus Synergies Expanding Evidence-Based Treatment for Alcohol Use Disorder through Follow-on Investment in Alavida Health
Vancouver, British Columbia, August 22, 2018 – Nimbus Synergies, investor, partner, and mentor to British Columbia’s leading digital health companies, today announced its second investment in Alavida Health to support the treatment of alcohol use disorder through its continued growth and market expansion.
Nimbus Synergies Transforming Concussion Testing and Management through Investment in HeadCheck Health
Vancouver, British Columbia, August 15, 2018 – Nimbus Synergies, investor, partner, and mentor to British Columbia’s leading digital health companies, today announced that it has performed an extensive due diligence process and has announced the fifth company in its investment portfolio.
